nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cardiovascular risk reduction: The role of antihypertensive treatment
|
Kaplan, Norman M. |
|
1991 |
90 |
2S1 |
p. S19-S20 2 p. |
artikel |
2 |
Concluding remarks
|
Schoenberger, James A. |
|
1991 |
90 |
2S1 |
p. S87-S88 2 p. |
artikel |
3 |
Diabetic nephropathy: Can the natural history be modified?
|
Narins, Robert G. |
|
1991 |
90 |
2S1 |
p. S70-S75 6 p. |
artikel |
4 |
Diabetic retinopathy: Can we modify its course?
|
Rand, Lawrence I. |
|
1991 |
90 |
2S1 |
p. S66-S69 4 p. |
artikel |
5 |
Evolving natural history of coronary artery disease in diabetes mellitus
|
Krolewski, Andrzej S. |
|
1991 |
90 |
2S1 |
p. S56-S61 6 p. |
artikel |
6 |
Hypertension, endothelium, and cardiovascular risk factors
|
Raij, Leopoldo |
|
1991 |
90 |
2S1 |
p. S13-S18 6 p. |
artikel |
7 |
Insulin as a mitogenic factor: Role in the pathogenesis of cardiovascular disease
|
Stout, Robert W. |
|
1991 |
90 |
2S1 |
p. S62-S65 4 p. |
artikel |
8 |
Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension
|
Reaven, Gerald M. |
|
1991 |
90 |
2S1 |
p. S7-S12 6 p. |
artikel |
9 |
Introduction
|
Schoenberger, James A. |
|
1991 |
90 |
2S1 |
p. S1- 1 p. |
artikel |
10 |
Management of hypertension and cardiovascular risk
|
Hollenberg, Norman K. |
|
1991 |
90 |
2S1 |
p. S2-S6 5 p. |
artikel |
11 |
Publisher's note
|
|
|
1991 |
90 |
2S1 |
p. iii- 1 p. |
artikel |
12 |
Regression of atherosclerosis: What does it mean?
|
Blankenhorn, David H. |
|
1991 |
90 |
2S1 |
p. S42-S47 6 p. |
artikel |
13 |
The national cholesterol education program: Guidelines, status, and issues
|
Goodman, DeWitt S. |
|
1991 |
90 |
2S1 |
p. S32-S35 4 p. |
artikel |
14 |
The tangled web of coronary risk factors
|
Krauss, Ronald M. |
|
1991 |
90 |
2S1 |
p. S36-S41 6 p. |
artikel |
15 |
Workshop I—Fifth joint national committee report: How should it differ from the 1988 report?
|
Porush, Co-Chairmen Jerome G. |
|
1991 |
90 |
2S1 |
p. S21-S23 3 p. |
artikel |
16 |
Workshop II-Hypertension trials and meta-analyses: Is there any value for further studies?
|
Grimm Jr., Co-Chairmen Richard H. |
|
1991 |
90 |
2S1 |
p. S24-S25 2 p. |
artikel |
17 |
Workshop III—Insulin resistance: Is it truly the link?
|
Izzo Jr., Co-Chairmen Joseph L. |
|
1991 |
90 |
2S1 |
p. S26-S31 6 p. |
artikel |
18 |
Workshop IV—National cholesterol education program guidelines: Are they clinically relevant?
|
Donald Hunninghake, Chairman |
|
1991 |
90 |
2S1 |
p. S48-S49 2 p. |
artikel |
19 |
Workshop IX—Lipids, insulin, diabetes
|
Simonson, Co-Chairman Donald C. |
|
1991 |
90 |
2S1 |
p. S85-S86 2 p. |
artikel |
20 |
Workshop VIII—Retinopathy, nephropathy, neuropathy, and tight control
|
Lebovitz, Co-Chairmen Harold E. |
|
1991 |
90 |
2S1 |
p. S80-S84 5 p. |
artikel |
21 |
Workshop VII—Patient population and genetics: Role in diabetes
|
Bennett, Co-Chairmen Peter H. |
|
1991 |
90 |
2S1 |
p. S76-S79 4 p. |
artikel |
22 |
Workshop VI—Regression of atherosclerosis: What does it mean?
|
Brown, Chairman B.Greg |
|
1991 |
90 |
2S1 |
p. S53-S55 3 p. |
artikel |
23 |
Workshop V—What is a risk factor and what is not—Theoretical and practical implications
|
Pearson, Chairman Thomas A. |
|
1991 |
90 |
2S1 |
p. S50-S52 3 p. |
artikel |